Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)

BACKGROUND: Non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have substantially improved anticoagulation therapy for prevention of stroke and systemic embolism in patients with atrial fibrillation (AF). The available routine care data have demonstrated the safety of different NOACs; howeve...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cardiovasc Disord
Autori principali: De Caterina, Raffaele, Kelly, Peter, Monteiro, Pedro, Deharo, Jean Claude, de Asmundis, Carlo, López-de-Sá, Esteban, Weiss, Thomas W., Waltenberger, Johannes, Steffel, Jan, de Groot, Joris R., Levy, Pierre, Bakhai, Ameet, Zierhut, Wolfgang, Laeis, Petra, Kerschnitzki, Michael, Reimitz, Paul-Egbert, Kirchhof, Paulus
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6625115/
https://ncbi.nlm.nih.gov/pubmed/31299906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-019-1144-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi